Trials / Unknown
UnknownNCT02137733
The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- Mebix Inc · Industry
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the non-inferiority of bisoprolol to carvedilol by evaluating tolerability (The probability that administered maintenance dose reaches the maximum will be determined as an indicator) as a primary endpoint when bisoprolol or carvedilol is administered for 48 weeks to Japanese chronic heart failure patients. In addition, the safety and efficacy of bisoprolol will be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bisoprolol | |
| DRUG | Carvedilol |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2016-05-01
- First posted
- 2014-05-14
- Last updated
- 2014-05-14
Locations
110 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02137733. Inclusion in this directory is not an endorsement.